I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-R..:
Gettinger, Scott N
;
Huber, Rudolf M
;
Kim, Dong-Wan
...
JTO Clinical and Research Reports, Vol.3 No.9, p. 100385. , 2023
Link:
https://hdl.handle.net/10371/192475
RT Journal T1
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_192475&Exemplar=1&LAN=DE A1 Gettinger, Scott N A1 Huber, Rudolf M A1 Kim, Dong-Wan A1 Bazhenova, Lyudmila A1 Hansen, Karin Holmskov A1 Tiseo, Marcello A1 Langer, Corey J A1 Paz-Ares Rodríguez, Luis G A1 West, Howard L A1 Reckamp, Karen L A1 Weiss, Glen J A1 Smit, Egbert F A1 Hochmair, Maximilian J A1 Kim, Sang-We A1 Ahn, Myung-Ju A1 Kim, Edward S A1 Groen, Harry J.M A1 Pye, Joanna A1 Liu, Yuyin A1 Zhang, Pingkuan A1 Vranceanu, Florin A1 Camidge, D. Ross PB Elsevier YR 2023 K1 ALK tyrosine kinase inhibitor K1 Anaplastic lymphoma kinase K1 Brigatinib K1 Crizotinib K1 Non–small-cell lung cancer JF JTO Clinical and Research Reports, Vol.3 No.9, p. 100385 LK http://dx.doi.org/https://hdl.handle.net/10371/192475 DO https://hdl.handle.net/10371/192475 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)